118 related articles for article (PubMed ID: 11375523)
1. Crystallization and preliminary X-ray analysis of the complex between human CTLA-4 and B7-2.
Zhang X; Schwartz JC; Nathenson SG; Almo SC
Acta Crystallogr D Biol Crystallogr; 2001 Jun; 57(Pt 6):898-9. PubMed ID: 11375523
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
Schwartz JC; Zhang X; Fedorov AA; Nathenson SG; Almo SC
Nature; 2001 Mar; 410(6828):604-8. PubMed ID: 11279501
[TBL] [Abstract][Full Text] [Related]
3. Expression, refolding, purification, molecular characterization, crystallization, and preliminary X-ray analysis of the receptor binding domain of human B7-2.
Zhang X; Schwartz JC; Almo SC; Nathenson SG
Protein Expr Purif; 2002 Jun; 25(1):105-13. PubMed ID: 12071705
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary X-ray analysis of CTLA-4 (CD152) membrane-external domain.
Chang CY; Fenderson WH; Lavoie TB; Peach RJ; Einspahr HM; Sheriff S
Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1468-9. PubMed ID: 11053855
[TBL] [Abstract][Full Text] [Related]
5. Construction and expression in the yeast Pichia pastoris of functionally active soluble forms of the human costimulatory molecules B7-1 and B7-2 and the B7 counter-receptor CTLA-4.
Gerstmayer B; Pessara U; Wels W
FEBS Lett; 1997 Apr; 407(1):63-8. PubMed ID: 9141482
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling.
Zhang X; Schwartz JC; Almo SC; Nathenson SG
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2586-91. PubMed ID: 12606712
[TBL] [Abstract][Full Text] [Related]
7. The interaction properties of costimulatory molecules revisited.
Collins AV; Brodie DW; Gilbert RJ; Iaboni A; Manso-Sancho R; Walse B; Stuart DI; van der Merwe PA; Davis SJ
Immunity; 2002 Aug; 17(2):201-10. PubMed ID: 12196291
[TBL] [Abstract][Full Text] [Related]
8. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.
Truneh A; Reddy M; Ryan P; Lyn SD; Eichman C; Couez D; Hurle MR; Sekaly RP; Olive D; Sweet R
Mol Immunol; 1996 Feb; 33(3):321-34. PubMed ID: 8649453
[TBL] [Abstract][Full Text] [Related]
9. Intracellular capture of B7 in antigen-presenting cells reduces costimulatory activity.
Sheriff A; Vogt B; Baumgart M; Montag C; Hollenbach B; Schenk JA; Ulrich J; Elías F; Micheel B
Biochem Biophys Res Commun; 2003 Feb; 301(4):873-8. PubMed ID: 12589793
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.
Stamper CC; Zhang Y; Tobin JF; Erbe DV; Ikemizu S; Davis SJ; Stahl ML; Seehra J; Somers WS; Mosyak L
Nature; 2001 Mar; 410(6828):608-11. PubMed ID: 11279502
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
Morton PA; Fu XT; Stewart JA; Giacoletto KS; White SL; Leysath CE; Evans RJ; Shieh JJ; Karr RW
J Immunol; 1996 Feb; 156(3):1047-54. PubMed ID: 8557978
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand-deficient mice.
Schneider H; Mandelbrot DA; Greenwald RJ; Ng F; Lechler R; Sharpe AH; Rudd CE
J Immunol; 2002 Oct; 169(7):3475-9. PubMed ID: 12244135
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of the cDNAs encoding the feline B-lymphocyte activation antigen B7-1 (CD80) and B7-2 (CD86) homologues which interact with human CTLA4-Ig.
Nishimura Y; Shimojima M; Miyazawa T; Sato E; Nakamura K; Izumiya Y; Ikeda Y; Mikami T; Takahashi E
Eur J Immunogenet; 2000; 27(5-6):427-30. PubMed ID: 11029611
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.
Metzler WJ; Bajorath J; Fenderson W; Shaw SY; Constantine KL; Naemura J; Leytze G; Peach RJ; Lavoie TB; Mueller L; Linsley PS
Nat Struct Biol; 1997 Jul; 4(7):527-31. PubMed ID: 9228944
[TBL] [Abstract][Full Text] [Related]
15. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
Frauwirth KA; Alegre ML; Thompson CB
J Immunol; 2000 Mar; 164(6):2987-93. PubMed ID: 10706686
[TBL] [Abstract][Full Text] [Related]
16. The role of B7 costimulation in T-cell immunity.
Harris NL; Ronchese F
Immunol Cell Biol; 1999 Aug; 77(4):304-11. PubMed ID: 10457196
[TBL] [Abstract][Full Text] [Related]
17. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.
Vaughan AN; Malde P; Rogers NJ; Jackson IM; Lechler RI; Dorling A
J Immunol; 2000 Sep; 165(6):3175-81. PubMed ID: 10975832
[TBL] [Abstract][Full Text] [Related]
18. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.
Darlington PJ; Kirchhof MG; Criado G; Sondhi J; Madrenas J
J Immunol; 2005 Jul; 175(2):996-1004. PubMed ID: 16002699
[TBL] [Abstract][Full Text] [Related]
19. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2.
Wagner DH; Hagman J; Linsley PS; Hodsdon W; Freed JH; Newell MK
J Exp Med; 1996 Nov; 184(5):1631-8. PubMed ID: 8920853
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
